納豆激酶 Nattokinase
C 3
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場:cautious
Reduce build-up in the arteries thus improving blood flow and circulation; remove excess fibrin and plaque that may have been building for years, and restore healthy blood flow
來源 ↗ L4b · EU EFSA
立場:neutral
L4c · UK NHS
立場:not_addressed
L4e · WHO
立場:not_addressed
市場與行銷 (L10)
L10a · TW Market Channels
市面上常見的納豆激酶補充品,單日建議攝取量從 2,000FU 到 5,000FU 皆有,而消費者在選購時,能優先參考 5,000FU 的產品
L10b · TW Legal Identity (TFDA)
食品廣告標示詞句涉及誇張易生誤解或醫療效能之認定表(食藥署 101 年 9 月 28 日署授食字第 1013000020 號令發布)
L10c · TW Community (PTT/Dcard/Mobile01)
吃了三年健檢數值都保持在正常值~蠻有效的